Granulocyte-colony stimulating factor in acute-on-chronic liver failure: Systematic review and meta-analysis of randomized controlled trials

Moreau, 2013, Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis, Gastroenterology., 144, 1426, 10.1053/j.gastro.2013.02.042 Martin-Mateos, 2019, Dysfunctional immune response in acute-on-chronic liver failure: it takes two to tango, Front Immunol., 10, 1, 10.3389/fimmu.2019.00973 Artru, 2017, Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3, J Hepatol., 67, 708, 10.1016/j.jhep.2017.06.009 Spahr, 2008, Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: A randomized trial, Hepatology., 48, 221, 10.1002/hep.22317 Garg, 2012, Granulocyte colony–stimulating factor mobilizes cd34+ cells and improves survival of patients with acute-on-chronic liver failure, Gastroenterology., 142, 505, 10.1053/j.gastro.2011.11.027 Mark, 2010, Stem cell mobilization is life saving in an animal model of acute liver failure, Ann Surg., 252, 591, 10.1097/SLA.0b013e3181f4e479 Saha, 2017, Therapeutic implications of granulocyte colony stimulating factor in patients with acute-on-chronic liver failure: increased survival and containment of liver damage, Hepatol Int., 11, 540, 10.1007/s12072-017-9814-1 Duan, 2013, Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure, World J Gastroenterol., 19, 1104, 10.3748/wjg.v19.i7.1104 Engelmann, 2021, Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: A multicenter randomized trial (GRAFT study), J Hepatol., 1 Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration, Ann Intern Med., 151, 10.7326/0003-4819-151-4-200908180-00136 Sarin, 2009, Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL), Hepatol Int., 3, 269, 10.1007/s12072-008-9106-x Chavez-Tapia, 2015, Granulocyte-colony stimulating factor for acute-on-chronic liver failure: systematic review and meta-analysis, Ann Hepatol., 14, 631, 10.1016/S1665-2681(19)30757-4 Sterne, 2019, RoB 2: a revised tool for assessing risk of bias in randomised trials, BMJ., l4898, 10.1136/bmj.l4898 Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ WV (editors). Cochrane handbook for systematic reviews of interventions version 6.0 (updated July 2019). Available from www.training.cochrane.org/handbook; 2019. Thapaliya, 2017, Granulocyte colony stimulating factor in decompensated liver disease - our experience in a tertiary hospital in Nepal, United Eur Gastroenterol J., 5 Pathak, 2019, Use of granulocyte colony-stimulating factor among patients of chronic liver disease in a tertiary hospital in nepal: a pilot study, Med J Shree Birendra Hosp., 18, 53, 10.3126/mjsbh.v18i2.23038 Di Campli, 2007, Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure, Dig Liver Dis., 39, 1071, 10.1016/j.dld.2007.08.006 Kedarisetty, 2015, Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis, Gastroenterology., 148, 10.1053/j.gastro.2015.02.054 Garg, 2011, Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure, Hepatology., 53, 774, 10.1002/hep.24109 Sharma, 2020, Role of granulocyte colony stimulating factor on the short-term outcome of children with acute on chronic liver failure, J Clin Exp Hepatol., 10, 201, 10.1016/j.jceh.2019.10.001 Marot, 2020, Granulocyte colony-stimulating factor for alcoholic hepatitis: A systematic review and meta-analysis of randomised controlled trials, JHEP Reports., 2, 100139, 10.1016/j.jhepr.2020.100139